1. Vanaerschot, M, Murithi, JM, Pasaje, CFA, Ghidelli-Disse, S, Dwomoh, L, Bird, M et al.. Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity. Cell Chem Biol. 2020; :. doi: 10.1016/j.chembiol.2020.04.001. PubMed PMID:32359426 .
2. LaMonte, GM, Rocamora, F, Marapana, DS, Gnädig, NF, Ottilie, S, Luth, MR et al.. Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway. Nat Commun. 2020;11 (1):1780. doi: 10.1038/s41467-020-15440-4. PubMed PMID:32286267 PubMed Central PMC7156427.
3. Abraham, M, Gagaring, K, Martino, ML, Vanaerschot, M, Plouffe, DM, Calla, J et al.. Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials. ACS Infect Dis. 2020;6 (4):613-628. doi: 10.1021/acsinfecdis.9b00482. PubMed PMID:32078764 PubMed Central PMC7155171.
4. Murithi, JM, Owen, ES, Istvan, ES, Lee, MCS, Ottilie, S, Chibale, K et al.. Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery. Cell Chem Biol. 2020;27 (2):158-171.e3. doi: 10.1016/j.chembiol.2019.11.009. PubMed PMID:31813848 PubMed Central PMC7031696.
5. Mandt, REK, Lafuente-Monasterio, MJ, Sakata-Kato, T, Luth, MR, Segura, D, Pablos-Tanarro, A et al.. In vitro selection predicts malaria parasite resistance to dihydroorotate dehydrogenase inhibitors in a mouse infection model. Sci Transl Med. 2019;11 (521):. doi: 10.1126/scitranslmed.aav1636. PubMed PMID:31801884 .

Find us social!